Compare DY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DY | NBIX |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 13.2B |
| IPO Year | N/A | 1996 |
| Metric | DY | NBIX |
|---|---|---|
| Price | $400.47 | $141.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 21 |
| Target Price | ★ $373.20 | $176.24 |
| AVG Volume (30 Days) | 380.4K | ★ 1.1M |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.70 | 12.44 |
| EPS | ★ 10.15 | 4.19 |
| Revenue | ★ $5,172,874,000.00 | $2,682,700,000.00 |
| Revenue This Year | $18.61 | $23.55 |
| Revenue Next Year | $23.92 | $19.18 |
| P/E Ratio | $39.45 | ★ $33.69 |
| Revenue Growth | 13.19 | ★ 19.61 |
| 52 Week Low | $131.37 | $84.23 |
| 52 Week High | $402.33 | $160.18 |
| Indicator | DY | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 52.05 |
| Support Level | $349.67 | $136.46 |
| Resistance Level | $402.33 | $141.45 |
| Average True Range (ATR) | 16.93 | 3.46 |
| MACD | 0.26 | 0.84 |
| Stochastic Oscillator | 69.60 | 79.76 |
Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. Its operating companies supply telecommunications providers with a comprehensive portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services and provide underground facility locating services for various utilities, including telecommunications providers, and others. It also provides a range of construction, maintenance, and installation services, including the placement and splicing of fiber, copper, and coaxial cables. It provides services throughout the United States.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.